📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency. (2023)

First Author: Seker Yilmaz B

Attributed to: Phase I/II clinical trial evaluating AAV-mediated gene therapy for a severe paediatric metabolic liver disease: Ornithine Transcarbamylase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/biomedicines11082227

PubMed Identifier: 37626723

Publication URI: http://europepmc.org/abstract/MED/37626723

Type: Journal Article/Review

Volume: 11

Parent Publication: Biomedicines

Issue: 8

ISSN: 2227-9059